Abstract
Cholesterol is a relatively small (molecular weight 387) hydrocarbon molecule that is ubiquitous in mammalian cells. There is about 150 g of cholesterol in the body, most of which serves structural purposes in the lipid bilayers that comprise cellular membranes; about two-thirds of the cholesterol is in nervous, muscle, and connective tissues. Almost all tissues of the body have the capability of synthesizing cholesterol but generally do not because their needs are met by the circulating sterol. Only about 8 g can be found circulating in the plasma. Because of cholesterol’s statistical association with coronary heart disease, plasma cholesterol has been studied exhaustively as a factor in the genesis of atherosclerosis but has also been examined in relation to a variety of other conditions including cancer and immunologic responses. The importance of cholesterol in biological membranes derives from its ability to affect the fluidity via its interaction with phospholipids. This interaction controls membrane permeability, membrane electrical activity, and membrane metabolic activity and expression of glycoprotein receptors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antonaci, S., Jirillo, E., Garofalo, A. R., Polignano, A., Resta, F., Pugliese, P., Capurso, A., and Bonomo, L., 1988, Cell-mediated immune response in patients with type IIa, type IIb and type IV primary hyperlipoproteinaemia, Cytobios. 54: 181–189.
Austin, M. A., King, M. C., Bawol, R. D., Hulley, S. B., and Friedman, G. D., 1987, Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences, Am. J. Epidemiol 125: 308–318.
Bath, P. M. W., Gladwin, A. M., and Martin, J. F., 1991, Human monocyte characteristics are altered in hypercholesterolaemia, Atherosclerosis 90: 175–181.
Berry, E. M., Hirsch, J., Most, J., McNamara, D. J., and Cunningham-Rundles, S., 1987, Dietary fat, plasma lipoproteins, and immune function in middle-aged American men, Nutr. Cancer 9: 129–142.
Bigler, R. D., Khoo, M., Lund-Katz, S., Scerbo, L., and Esfahani, M., 1990, Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis, Proc. Natl. Acad. Sci. USA 87: 4981–4985.
Brito, B., Romano, E., and Soyano, A., 1989, Functional characterization of mononuclear cells of normal and hypercholesterolemic rabbits, J. Med. 20: 273–285.
Carlomagno, M. A., O’Brien, B. C., and McMurray, D. N., 1983, Influence of early weaning and dietary fat on immune responses in adult rats, J. Nutr. 113: 610–617.
Carnazzo, G., Mirone, G., Tutturici, A., Favetta, A., Campo, M. E., Cosenza, C., Chiarenza, G., and Stivala, F., 1989, Pathophysiology of the immune system in elderly subjects with or without diabetes and variations after recombinant interleukin-2, Arch. Gerontol. Geriatr. 9: 163–180.
Chapman, H. A., and Hibbs, J. B., 1977, Modulation of macrophage tumoricidal capability by components of normal serum: A central role for lipid, Science 197: 282–285.
Curtiss, L. K., DeHeer, D. H., and Edgington, T. S., 1977, In vivo suppression of the primary immune response by a species of low density serum lipoprotein, J. Immunol. 118: 648–652.
Cuthbert, J. A., and Lipsky, P. E., 1986, Low-density lipoprotein (LDL) and lymphocyte responses: Direct suppression by native LDL and indirect inhibition from zinc chelation by contaminating EDTA, Biochim. Biophys. Acta 876: 210–219.
Cuthbert, J. A., and Lipsky, P. E., 1987, Regulation of lymphocyte proliferation by cholesterol: The role of endogenous sterol metabolism and low density lipoprotein receptors, Int. J. Tissue React. 9: 447–457.
Dewey, K., and Nuzum, F., 1914, The effect of cholesterol on phagocytosis, J. Infect. Dis. 15: 472–478.
Duwe, A. K., Fitch, M., and Ostwald, R., 1981, Effects of dietary cholesterol on antibody-dependent phagocytosis and cell-mediated lysis in guinea pigs, J. Nutr. 111: 1672–1680.
Duwe, A. K., Fitch, M., and Ostwald, R., 1984, Depressed natural killer and lectin-induced cell-mediated cytotoxicity in cholesterol-fed guinea pigs, J. Natl. Cancer Inst. 72: 333–338.
Feo, F., Canuto, R. A., Torrielli, M. V., Garcea, R., and Dianzani, M. U., 1976, Effect of a cholesterol-rich diet on cholesterol content and phagocytic activity of rat macrophages, Agents Actions 6: 135–142.
Fiser, R. H., Denniston, J. C., McGann, V. G., Kaplan, J., Adler, W. H., III, Kastello, M. D., and Beisel, W. R., 1973, Altered immune functions in hypercholesterolemic monkeys, Infect. Immun. 8: 105–109.
Ip, S. H. C., Abrahm, J., and Cooper, R. A., 1980, Enhancement of blastogenesis in cholesterol-enriched lymphocytes, J. Immunol. 124: 87–93.
Kelley, J. L., Suenram, C. A., Rozek, M. M., and Schwartz, C. J., 1988, Influence of hypercholesterolemia and cholesterol accumulation on rabbit carrageenan granuloma macrophage activation, Am. J. Pathol. 131: 539–546.
Klurfeld, D. M., 1983, Interactions of immune function with lipids and atherosclerosis, CRC Crit. Rev. Toxicol. 11: 333–365.
Klurfeld, D. M., Allison, M. J., Gerszten, E., and Dalton, H. P., 1979a, Alterations of host defenses paralleling cholesterol-induced atherogenesis. I. Interactions of prolonged experimental hypercholesterolemia and infections, J. Med. 10: 35–48.
Klurfeld, D. M., Allison, M. J., Gerszten, E., and Dalton, H. P., 1979b, Alterations of host defenses paralleling cholesterol-induced atherogenesis. II. Immunologic studies of rabbits, J. Med. 10: 49–64.
Leirisalo-Repo, M., Jaattela, M., Gylling, H., Miettinen, T. A., and Repo, H., 1990, Phagocyte function in familial hypercholesterolaemia: Peripheral blood monocytes exposed to lipopolysaccharide show increased tumour necrosis factor production, Scand. J. Immunol. 32: 679–685.
Levinson, S. A., 1931, Fat therapy in experimental tuberculosis of rabbits, Am. Rev. Tuberc. 23: 527–541.
McMichael, A. J., Jensen, O. M., Parkin, D. M., and Zaridze, D. G., 1984, Dietary and endogenous cholesterol and human cancer, Epidemiol. Rev. 6: 192–216.
Morse, J. H., Witte, L. D., and Goodman, D. S., 1977, Inhibition of lymphocyte proliferation stimulated by lectins and allogenic cells by normal plasma lipoproteins, J. Exp. Med. 146: 1791–1803.
Neveu, T., Biozzi, G., Benacerraf, B., Stiffel, C., and Halpern, B. N., 1956, Role of reticulo-endothelial system in blood clearance of cholesterol, Am. J. Physiol. 187: 269–274.
Ohtsuka, Y., Kobayashi, K., Hirano, T., Furukawa, S. I., Nagano, S., and Takahashi, T., 1990, Involvement of lipoproteins in suppression of interleukin 2-dependent cell proliferation by sera from aged humans, Gerontology 36: 268–275.
Pepe, M. G., and Curtiss, L. K., 1986, Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In, J. Immunol. 136: 3716–3723.
Pereira, CA., Steffan, A. M., Koehren, F., Douglas, C. R., and Kirn, A., 1987, Increased susceptibility of mice to MHV 3 infection induced by hypercholesterolemic diet: Impairment of Kupffer cell function, Immunobiology 174: 253–265.
Raska, K., Jr., Morrison, A. B., and Raskova, J., 1980, Humoral inhibitors of the immune response in uremia. III. The immunosuppressive factor of uremic rat serum is a very low density lipoprotein, Lab. Invest. 42: 636–642.
Roman-Franco, A. A., and Santiago-Delpin, E. A., 1977, The immunoregulatory role of cholesterol and other lipids: A hypothesis, Med. Hypoth. 3: 235–240.
Schulman, E. S., Quinn, T. J., Post, T. J., O’Donnell, P., Rodriguez, A., and Gonen, B., 1987, Low density lipoprotein (LDL) inhibits histamine release from human mast cells, Biochem. Biophys. Res. Commun. 148: 553–559.
Shope, R. H., 1928, The influence of cholesterol on experimental tuberculosis, J. Exp. Med. 48: 321–331.
Takemura-Hattori, R., Yamazaki, M., Kurisu, M., and Mizuno, D., 1980, Depression of macrophage function by lipoprotein from tumorous ascites, Gann. 71: 206–212.
Traill, K. N., Huber, L. A., Wick, G., and Jürgens, G., 1990, Lipoprotein interactions with T cells: An update, Immunol. Today 11: 411–417.
Tunnicliff, R., 1933, The influence of cholesterol on phagocytosis, J. Infect. Dis. 33: 285–293.
Waddell, C. C., Taunton, O. D., and Twomey, J. J., 1976, Inhibition of lymphoproliferation by hyperlipoproteinemic plasma, J. Clin. Invest. 58: 950–954.
Waelti, E. R., Burger, M., and Hess, M. H., 1981, Effects of low density lipoprotein (LDL) and apoprotein of LDL on the nonspecific stimulation of murine lymphocytes, Immunol. Lett. 2: 272–277.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Klurfeld, D.M. (1993). Cholesterol as an Immunomodulator. In: Klurfeld, D.M. (eds) Nutrition and Immunology. Human Nutrition. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2900-2_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2900-2_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6257-9
Online ISBN: 978-1-4615-2900-2
eBook Packages: Springer Book Archive